USA | Imports and Exports | World | Hormones, prostaglandins, thromboxanes and leukotrienes, derivatives and structural analogues thereof | Value (US$) and Value Growth, YoY (%) | 2012 - 2023
The value of exports of commodity group 2937 "Hormones, prostaglandins, thromboxanes and leukotrienes, natural or reproduced by synthesis; derivatives and structural analogues thereof, including chain modified polypeptides, used primarily as hormones" from USA totalled $ 6.3 billion in 2023. Sales of commodity group 2937 from USA went up by 169% compared to 2022: exports of commodity group 2937 "Hormones, prostaglandins, thromboxanes and leukotrienes, natural or reproduced by synthesis; derivatives and structural analogues thereof, including chain modified polypeptides, used primarily as hormones" went up by $ 3.96 billion (cumulative exports of commodity group 2937 from USA amounted $2.33 billion in 2022)
Exports of commodity group 2937 "Hormones, prostaglandins, thromboxanes and leukotrienes, natural or reproduced by synthesis; derivatives and structural analogues thereof, including chain modified polypeptides, used primarily as hormones" amounted to 0.312% of total exports from USA (cumulative merchandise exports from USA totalled $ 2.01 trillion in 2023). The share of commodity group 2937 in total exports from USA increased by 0.198 p.p. compared to 2022 (it was 0.113% in 2022 and cumulative exports from USA were equal to $ 2.06 trillion).
Exports of commodity group 2937 amounted to 12.1% of total sales of group "" from USA in 2023 (the value of exports of commodity group from USA amounted to $51 billion in 2023). The share of exports of commodity group 2937 in sales of commodity group from USA increased by 7.6 p.p. compared to 2022 (it was 4.57% in 2022, and exports of commodity group from USA were $51 billion).
Where does USA export Hormones, prostaglandins, thromboxanes and leukotrienes, natural or reproduced by synthesis; derivatives and structural analogues thereof, including chain modified polypeptides, used primarily as hormones?
Top export destinations of "Hormones, prostaglandins, thromboxanes and leukotrienes, natural or reproduced by synthesis; derivatives and structural analogues thereof, including chain modified polypeptides, used primarily as hormones" from USA in 2023:
- Italy with a share of 51% (3.24 billion US$)
- Germany with a share of 24% (1.52 billion US$)
- Austria with a share of 8.87% (559 million US$)
- France with a share of 4.53% (285 million US$)
- Denmark with a share of 4.25% (267 million US$)
- Spain with a share of 1.54% (97 million US$)
- China with a share of 1.46% (92 million US$)
- Belgium with a share of 1.24% (78 million US$)
- Ireland - 22 million US$
- United Kingdom - 19 million US$
Exports structure of 2937 - Hormones, prostaglandins, thromboxanes and leukotrienes, natural or reproduced by synthesis; derivatives and structural analogues thereof, including chain modified polypeptides, used primarily as hormones - from USA in 2023 represented by the following main commodity groups:
- 81% (5.1 billion US$): 293719 - Polypeptide hormones, protein hormones & glycoprotein hormones, their derivatives & structural analogues (excl. of 2937.11 & 2937.12)
- 8.2% (517 million US$): 293712 - Insulin & its salts
- 7.36% (464 million US$): 293729 - Steroidal hormones, their derivatives & structural analogues (excl. of 2937.21-2937.23)
- 1.09% (69 million US$): 293711 - Somatotropin, its derivatives & structural analogues
- 0.84% (52 million US$): 293723 - Oestrogens & progestogens
- 0.56% (35 million US$): 293750 - Prostaglandins, thromboxanes & leukotrienes, their derivatives & structural analogues
- 0.396% (24 million US$): 293790 - Hormones, prostaglandins, thromboxanes and leukotrienes, natural or reproduced by synthesis; derivatives and structural analogues thereof, including chain modified polypeptides, used primarily as hormones, n.e.c. in heading 2937
- 0.279% (17.6 million US$): 293721 - Cortisone, hydrocortisone, prednisone (dehydrocortisone) & prednisolone (dehydrohydrocortisone)
- 0.204% (12.8 million US$): 293722 - Halogenated derivatives of corticosteroidal hormones
The value of imports of commodity group 2937 "Hormones, prostaglandins, thromboxanes and leukotrienes, natural or reproduced by synthesis; derivatives and structural analogues thereof, including chain modified polypeptides, used primarily as hormones" to USA totalled $ 11 billion in 2023. Sales of commodity group 2937 to USA went up by 52% compared to 2022: imports of commodity group 2937 "Hormones, prostaglandins, thromboxanes and leukotrienes, natural or reproduced by synthesis; derivatives and structural analogues thereof, including chain modified polypeptides, used primarily as hormones" went up by $ 3.77 billion (the value of imports of commodity group 2937 to USA was equal to $7.24 billion in 2022)
Imports of commodity group 2937 "Hormones, prostaglandins, thromboxanes and leukotrienes, natural or reproduced by synthesis; derivatives and structural analogues thereof, including chain modified polypeptides, used primarily as hormones" accounted for 0.347% of total import flow to USA (in 2023, total imports to USA amounted to $ 3.16 trillion). The share of commodity group 2937 in total imports to USA increased by 0.132 p.p. compared to 2022 (it was 0.214% in 2022 and cumulative imports to USA were equal to $ 3.37 trillion).
Imports of commodity group 2937 reached 16.5% of total imports of group "" to USA in 2023 (imports of commodity group to USA totalled $66 billion in 2023). The share of purchases of commodity group 2937 in total imports of commodity group to USA increased by 7 p.p. compared to 2022 (it was 9.54% in 2022, and imports of commodity group to USA accounted for $75 billion).
Where does USA import Hormones, prostaglandins, thromboxanes and leukotrienes, natural or reproduced by synthesis; derivatives and structural analogues thereof, including chain modified polypeptides, used primarily as hormones from?
Top trading partners (import of "Hormones, prostaglandins, thromboxanes and leukotrienes, natural or reproduced by synthesis; derivatives and structural analogues thereof, including chain modified polypeptides, used primarily as hormones") of USA in 2023:
- Ireland with a share of 71% (7.85 billion US$)
- Singapore with a share of 15.1% (1.66 billion US$)
- Argentina with a share of 4.95% (546 million US$)
- Italy with a share of 1.79% (197 million US$)
- Denmark with a share of 1.47% (162 million US$)
- France with a share of 1.41% (155 million US$)
- China with a share of 1.32% (145 million US$)
- Switzerland - 48 million US$
- Sweden - 40 million US$
- India - 35 million US$
Imports structure of 2937 - Hormones, prostaglandins, thromboxanes and leukotrienes, natural or reproduced by synthesis; derivatives and structural analogues thereof, including chain modified polypeptides, used primarily as hormones - to USA in 2023 represented by the following main commodity groups:
- 78% (8.68 billion US$): 293719 - Polypeptide hormones, protein hormones & glycoprotein hormones, their derivatives & structural analogues (excl. of 2937.11 & 2937.12)
- 15.4% (1.7 billion US$): 293722 - Halogenated derivatives of corticosteroidal hormones
- 1.86% (205 million US$): 293729 - Steroidal hormones, their derivatives & structural analogues (excl. of 2937.21-2937.23)
- 1.8% (199 million US$): 293790 - Hormones, prostaglandins, thromboxanes and leukotrienes, natural or reproduced by synthesis; derivatives and structural analogues thereof, including chain modified polypeptides, used primarily as hormones, n.e.c. in heading 2937
- 0.783% (86 million US$): 293712 - Insulin & its salts
- 0.704% (77 million US$): 293723 - Oestrogens & progestogens
- 0.243% (26 million US$): 293721 - Cortisone, hydrocortisone, prednisone (dehydrocortisone) & prednisolone (dehydrohydrocortisone)
- 0.216% (23 million US$): 293750 - Prostaglandins, thromboxanes & leukotrienes, their derivatives & structural analogues
- 0.06% (6.65 million US$): 293711 - Somatotropin, its derivatives & structural analogues
